Yun Dai
Fujian Medical University
11 Papers
6 Citations
Yun Dai is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma
Shulan Han,Xueying Bao,Yifang Zou,Lingzhi Wang,Yutong Li,Leilei Yang,Anqi Liao,Xin Jiang,Di Liang,Yun Dai,Qing-Chuan Zheng,Zhuo Yu,Jia Guo +12 more
TL;DR: In this article , the potential of DL for transformation of TAMs from M2 to M1 phenotype demonstrates great potential for remodeling the immunosuppressive tumor microenvironment (TME) of hepatocellular carcinoma (HCC).
89
What is the appropriate duration of adjuvant imatinib mesylate treatment for primary gastrointestinal stromal tumors classified according to the strict definition of tumor rupture
Jun Lu,Yun Dai,Hua-Long Zheng,Jian-Wei Xie,Jia-Bin Wang,Jian-Xian Lin,Qi-Yue Chen,Long-Long Cao,Mi Lin,Ru-Hong Tu,Ze-Ning Huang,Ju-Li Lin,Ping Li,Chang-Ming Huang,Chao-Hui Zheng +14 more
TL;DR: Tumor rupture according to KGSG's definition was an independent predictive factor associated with GIST patient prognosis and receiving IM treatment for more than 3 years was significantly associated with improved RFS and OS in GISTs patients with tumor rupture.
7
Dynamic monitoring of minimal residual disease in newly‐diagnosed multiple myeloma
Peiyu Yang,Weiling Xu,Xinyue Liang,Shanshan Yu,Xingcheng Yi,Meng Liu,Mengru Tian,Tingting Yue,Yingjie Zhang,Yurong Yan,Zhongli Hu,Qiang Guo,Nan Zhang,Jingxuan Wang,Xiaoxiao Sun,Rui-Ping Hu,Shaji Kumar,Yun Dai,Fengyan Jin +18 more
TL;DR: In this paper , the significance of dynamic monitoring of the MRD status in the management of NDMM patients was explored. But, several key issues remain to be addressed for incorporating MRD test into daily practice.
4
Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma
TL;DR: A case with early developing but highly revers-ible leukoencephalopathy during daratumumab treatment is reported.
The R2-ISS in a Multicenter Cohort of Chinese Patients With Newly Diagnosed Multiple Myeloma
Peiyu Yang,Fang Zhou,Yujun Dong,Guangxun Gao,Hua Xue,Xinyue Liang,Shanshan Yu,Weiling Xu,Yanping Ma,Xiaoqi Qin,Mengyao Li,Yun Dai,Fengyan Jin +12 more
TL;DR: In this article , the authors used the revised International Staging System (R-ISS) to predict the prognosis of multiple myeloma (MM) patients, which is a complex disease with highly heterogeneous tumor biology, especially involving cytogenetic abnormalities.
2